Stayble Therapeutics
Gothenburg, SE · Founded 2015 · 7 employees on LinkedIn · 1 known investors
Find your way into Stayble Therapeutics
109 people in our graph share verified history with the Stayble Therapeutics team — schools, employers, funds. One of them is your warm intro.
Alexander Fred-Ojalaunlockedknows Andreas Gerward · together at Chalmers University of Technology (overlapped)
×10knows the team · via Chalmers University of Technology
knows the team · via Investours
Stayble Therapeutics is a clinical-stage pharmaceutical company developing an injection-based treatment for disc herniation. The company is currently conducting phase 1b clinical trials for its therapeutic candidate.
Founders & leadership
AG
Andreas GerwardinCEOAndreas Gerward is CEO of Stayble Therapeutics, a clinical-stage pharmaceutical company developing injection-based treatments for disc herniation.
Investors · 1
In the news
Frequently asked questions
- What does Stayble Therapeutics do?
- Stayble Therapeutics is a clinical-stage pharmaceutical company developing an injection-based treatment for disc herniation. The company is currently conducting phase 1b clinical trials for its therapeutic candidate.
- Who are Stayble Therapeutics's investors?
- Stayble Therapeutics's investors include Chalmers Ventures AB.
- Where is Stayble Therapeutics headquartered?
- Stayble Therapeutics is headquartered in Gothenburg, SE.